NYSE · WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES · LARGE CAP
Accendra Health Inc. ACH
18 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in ACCENDRA HEALTH INC/VA/'s annual report to the U.S. Securities and Exchange Commission, filed 20 February 2026. Every sentence was checked against that document before publication.
Growth
USD 2.8B
Revenue, FY2025 · full 18-year series below
Revenue $B
Net income $B
FY2025 · Revenue 2.8 · Net income -1.1
Compound annual growth
−34.8%
−20.1%
−11.9%
−6.9%
−77.3%
−60.3%
−35.5%
+73.5%
−19.0%
−9.4%
3 yrs
5 yrs
10 yrs
15 yrs
Revenue compounded at −20.1% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−40 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating 1.0% · Net -39.8%
ROE
FY2025 · ROE -1755.6%
Each USD of equity lost 1756 cents this year.
The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 2.8 | 2.7 | 2.6 | 10.0 | 9.8 | 8.5 | 9.2 | 9.4 | 9.3 | 9.7 | 9.8 | 9.4 | 9.1 | 8.9 | 8.6 | 8.1 | 8.0 | 7.2 |
| Operating income $B | 0.0 | −0.2 | 0.1 | 0.1 | 0.4 | 0.2 | 0.1 | −0.4 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| EBITDA $B | 0.2 | −0.0 | 0.3 | 0.4 | 0.5 | 0.3 | 0.2 | −0.3 | 0.1 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | · | · | · | · |
| Income tax $B | 0.0 | 0.0 | 0.0 | −0.0 | 0.1 | 0.0 | −0.0 | −0.0 | −0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Net income $B | −1.1 | −0.4 | −0.0 | 0.0 | 0.2 | 0.0 | −0.1 | −0.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Free cash flow $B | −0.3 | −0.0 | 0.6 | 0.2 | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.2 | 0.2 | −0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.2 | 0.0 |
| EPS, diluted $ | −14.31 | −4.73 | −0.53 | 0.29 | 2.94 | 0.47 | −1.03 | −7.28 | 1.20 | 1.76 | 1.65 | 1.06 | 1.76 | 1.72 | 1.81 | 1.75 | 1.67 | 1.50 |
| Dividend / sh $ | · | · | · | · | 0.01 | 0.01 | 0.01 | 0.86 | 1.03 | 1.02 | 1.01 | 1.00 | 0.96 | 0.88 | 0.80 | 0.71 | 0.61 | 0.53 |
| Payout % | · | · | −0 | 0 | 0 | 2 | −8 | −11 | 87 | 58 | 62 | 95 | 55 | 51 | 44 | 40 | 37 | 35 |
| ROE % | −1755.6 | −47.4 | −4.3 | 2.4 | 26.9 | 5.1 | −12.7 | −57.0 | 7.2 | · | 10.4 | 6.6 | 11.1 | 11.5 | 13.0 | 13.6 | 14.4 | 13.5 |
| Shares out B | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 86 reconciliationsAUDITED
Reconciled in 18 of 19 fiscal years. 8 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityWholesale-Medical, Dental & Hospital Equipment & Supplies
Listed onNYSE
Incorporated inVirginia
Fiscal year endsDecember 31
Data on record since2008